Purpose
We previously demonstrated that CD44v9 and Ki-67 played an important role in predicting poor prognosis of early gastric cancer (EGC). However, little is known about combined use of both biomarkers as prognostic biomarker. The present study was performed to investigate the significance of CD44v9 and Ki-67 expression as a combination biomarker for EGC.
Materials and Methods
With tissue microarray for 158 EGC tissues, we performed immunohistochemical staining for CD44v9 and Ki-67. The whole patients were divided into three groups (group A, CD44v9- negative/Ki-67–low; group B, neither group A or C; and group C, CD44v9-positive/Ki-67– high). Its clinical significance was re-analyzed with adjustment via propensity score matching (PSM). For validation, we performed bootstrap resampling.
Results
The median follow-up duration was 90.4 months (range, 3.7 to 120.4 months). In the comparison according to CD44v9/Ki-67 expression, the combined use of the two biomarker clearly separated the three groups by 5-year survival rates (5-YSR, 96.3%, 89.8%, and 76.8% in group A, B, and C, respectively; p=0.009). After PSM, 5-YSR were 97.7% and 76.8% in group A+B and group C, respectively (p=0.002). Multivariable analysis demonstrated that group C had independently poor prognosis (hazard ratio, 9.137; 95% confidence interval, 1.187 to 70.366; p=0.034) compared with group A. Bootstrap resampling internally validated this result (p=0.016).
Conclusion
This study suggests that both positive CD44v9 and high Ki-67 expression are associated with poor prognosis in EGC, and the combined use of these markers provides better prognostic stratification than the single use of them.
Citations
Citations to this article as recorded by
The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach Mahdieh Razmi, Fatemeh Tajik, Farideh Hashemi, Ayna Yazdanpanah, Fatemeh Hashemi-Niasari, Adeleh Divsalar Journal of Gastrointestinal Cancer.2024; 55(2): 599. CrossRef
Impact of Alcian blue and periodic acid Schiff expression on the prognosis of gastric signet ring cell carcinoma Juan Lin, Zhu-Feng Chen, Guo-Dong Guo, Xin Chen World Journal of Gastrointestinal Oncology.2024; 16(3): 687. CrossRef
Significance of concurrent evaluation of HER2 gene amplification and p53 and Ki67 expression in gastric cancer tissues Su-nan Wang, Yang-kun Wang, Chao-ya Zhu, Bo Jiang, Dong-feng Ge, Ying-ying Li Clinical and Translational Oncology.2024; 27(1): 126. CrossRef
Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway Jie Wang, Ze Yu, Yixiao Jiang, Ting Le, Yixin Wu, Ziqi Li, Guoqiang Zhang, Feiyue Wu, Haijie Ma Frontiers in Bioscience-Landmark.2024;[Epub] CrossRef
Analysis of risk factors for lymph node metastasis and prognosis study in patients with early gastric cancer: A SEER data-based study Jinzhou Li, Ting Cui, Zeping Huang, Yanxi Mu, Yalong Yao, Wei Xu, Kang Chen, Haipeng Liu, Wenjie Wang, Xiao Chen Frontiers in Oncology.2023;[Epub] CrossRef
Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis (Review) Hiroshi Kobayashi, Shogo Imanaka, Hiroshi Shigetomi Oncology Letters.2022;[Epub] CrossRef
Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha Current Issues in Molecular Biology.2022; 44(3): 1395. CrossRef
Analysis of Endoscopy Findings to Identify Early Gastric Cancers with Tumor Budding: A Retrospective Study Lanqing Cao, Zhaoyong Wang, Liwei Duan, Lijuan Wei Journal of Gastrointestinal Surgery.2021; 25(7): 1706. CrossRef
Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma Jinbo Song, Zhe Yu, Bingqi Dong, Mingkai Zhu, Xiaofeng Guo, Yongkang Ma, Shiming Zhao, Tiejun Yang World Journal of Surgical Oncology.2021;[Epub] CrossRef
Fascin‑1 is associated with recurrence in solitary fibrous tumor/hemangiopericytoma Yumiko Yamamoto, Yoshihiro Hayashi, Hideyuki Sakaki, Ichiro Murakami Molecular and Clinical Oncology.2021;[Epub] CrossRef
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer Jie Yang Medical Oncology.2020;[Epub] CrossRef
Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression Jinfen Wei, Meiling Hu, Kaitang Huang, Shudai Lin, Hongli Du International Journal of Molecular Sciences.2020; 21(17): 5983. CrossRef
Haa-Na Song, Se-Il Go, Won Sup Lee, Yire Kim, Hye Jung Choi, Un Seok Lee, Myoung Hee Kang, Gyeong-Won Lee, Hoon-Gu Kim, Jung Hun Kang, Yune Sik Kang, Jeong-Hee Lee, Jin-Myung Jung, Soon Chan Hong
Cancer Res Treat. 2016;48(2):789-797. Published online July 14, 2015
Purpose The purpose of this study is to investigate differences in organ-specific cancer incidence according to the region and population size in Korea.
Materials and Methods We reviewed the data of the cancer registration program of Gyeongnam Regional Cancer Center between 2008 and 2011. Age-standardized rates of cancer incidence were analyzed according to population size of the region and administrative zone.
Results Incidence of thyroid cancer has been increasing rapidly in both urban and rural areas. However, the thyroid cancer incidence was much lower in rural areas than in urban areas and megalopolis such as Seoul. Gastric cancer was relatively more common in rural areas, in megalopolis near the sea (Ulsan, Busan, and Incheon), and other southern provinces (Chungcheongnam-do, Gyeongsangbuk-do, and Gyeongsangnam-do). A detailed analysis in Gyeongsangnam-do revealed that rural areas have relatively low incidence of thyroid and colorectal cancer, and relatively high incidence of gastric and lung cancer compared to urban areas.
Conclusion This study suggests that there are some differences in cancer incidence by population size. Thyroid and colorectal cancer incidence was increasing, and gastric and lung cancer was slightly decreasing in urban areas, whereas gastric and lung cancer incidence still remains high in rural areas.
Citations
Citations to this article as recorded by
Impact of regional medical self-sufficiency on mortality from cancer, stroke and myocardial infarction Il Yun, Jong Youn Moon Public Health.2025; 238: 59. CrossRef
Projection of future gastric cancer incidence and health‐care service demand by geographic area in Kanagawa, Japan Choy‐Lye Chei, Sho Nakamura, Kaname Watanabe, Ryo Watanabe, Akio Kurokawa, Taizo Iwane, Sayaka Itoh, Hiroto Narimatsu Cancer Science.2025; 116(2): 488. CrossRef
Preliminary reports of lung cancer screening with low-dose computed tomography: a nationwide performance on the Korean population in 2019–2020 Horim A. Hwang, Dong Jun Kim, Nan-He Yoon, Jae Kwan Jun, Mina Suh, Sunhwa Lee, Seongju Kim, Seung Eun Jung, Hooyeon Lee European Radiology.2025;[Epub] CrossRef
Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry Divya Khanna, Priyanka Sharma, Atul Budukh, Rajesh Vishwakarma, Anand N. Sharma, Sonali Bagal, Varsha Tripathi, Vijay Kumar Maurya, Pankaj Chaturvedi, Satyajit Pradhan BMC Cancer.2024;[Epub] CrossRef
What is the relationship between the local population change and cancer incidence in patients with dyslipidemia: Evidence of the impact of local extinction in Korea Wonjeong Jeong, Dong‐Woo Choi, Woorim Kim, Kyu‐Tae Han Cancer Medicine.2024;[Epub] CrossRef
Health expenditure trajectory and gastric cancer incidence in the National Health Insurance Senior Cohort: a nested case-control study Woo-Ri Lee, Ki-Bong Yoo, Jin-Won Noh, Minjee Lee BMC Health Services Research.2024;[Epub] CrossRef
Urban Scaling of Health Outcomes: a Scoping Review Edwin M. McCulley, Pricila H. Mullachery, Ana F. Ortigoza, Daniel A. Rodríguez, Ana V. Diez Roux, Usama Bilal Journal of Urban Health.2022; 99(3): 409. CrossRef
Loss of Novel Diversity in Human Gut Microbiota Associated with Ongoing Urbanization in China Shan Sun, Huijun Wang, Annie Green Howard, Jiguo Zhang, Chang Su, Zhihong Wang, Shufa Du, Anthony A. Fodor, Penny Gordon-Larsen, Bing Zhang, Emily B. Graham mSystems.2022;[Epub] CrossRef
Deciphering the impact of urban built environment density on respiratory health using a quasi-cohort analysis of 5495 non-smoking lung cancer cases Lan Wang, Wenyao Sun, Anne Vernez Moudon, Yong-Guan Zhu, Jinfeng Wang, Pingping Bao, Xiaojing Zhao, Xiaoming Yang, Yinghui Jia, Surong Zhang, Shuang Wu, Yuxi Cai Science of The Total Environment.2022; 850: 158014. CrossRef
Difference in medical service use among Korean gastric cancer survivors according to regional healthcare vulnerabilities: a cohort study Sung Hoon Jeong, Jae Hong Joo, Minah Park, Choa Yun, Soo Hyun Kang, Eun-Cheol Park, Yoon Dae Han, Sung-In Jang Supportive Care in Cancer.2022; 30(11): 9233. CrossRef
Apoptotic Effects of Anthocyanins from Vitis coignetiae Pulliat Are Enhanced by Augmented Enhancer of the Rudimentary Homolog (ERH) in Human Gastric Carcinoma MKN28 Cells Cheol Park, Won Sup Lee, Se-Il Go, Sang-Ho Jeong, Jiyun Yoo, Hee-Jae Cha, Young-Joon Lee, Heui-Soo Kim, Sun-Hee Leem, Hye Jung Kim, Gon Sup Kim, Soon-Chan Hong, Yung Hyun Choi International Journal of Molecular Sciences.2021; 22(6): 3030. CrossRef
Current therapeutic options for gastric adenocarcinoma C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad Saudi Journal of Biological Sciences.2021; 28(9): 5371. CrossRef
Impact of Rurality on National Trends in Thyroid Cancer Incidence and Long‐Term Survival Alexandria D. McDow, Whitney E. Zahnd, Peter Angelos, John D. Mellinger, Sabha Ganai The Journal of Rural Health.2020; 36(3): 326. CrossRef
Predicted Future Mortality Attributed to Increases in Temperature and PM10 Concentration under Representative Concentration Pathway Scenarios Jiyun Jung, Jae Young Lee, Hyewon Lee, Ho Kim International Journal of Environmental Research and Public Health.2020; 17(7): 2600. CrossRef
Polyphenols Extracted from Artemisia annua L. Exhibit Anti-Cancer Effects on Radio-Resistant MDA-MB-231 Human Breast Cancer Cells by Suppressing Stem Cell Phenotype, β-Catenin, and MMP-9 Young Shin Ko, Eun Joo Jung, Se-il Go, Bae Kwon Jeong, Gon Sup Kim, Jin-Myung Jung, Soon Chan Hong, Choong Won Kim, Hye Jung Kim, Won Sup Lee Molecules.2020; 25(8): 1916. CrossRef
Temporal and geographical variations in colorectal cancer incidence in Northern Iran 2004–2013 Susan Hasanpour-Heidari, Abdolreza Fazel, Shahryar Semnani, Seyyed-Reza Khandoozi, Taghi Amiriani, SeyedMehdi Sedaghat, Reza Hosseinpoor, Ramin Azarhoush, Mohammad Poorabbasi, Mohammad Naeimi-Tabiei, Gholamreza Roshandel, Freddie Bray, Elisabete Weiderpas Cancer Epidemiology.2019; 59: 143. CrossRef
Regional Differences in Years of Life Lost in Korea from 1997 to 2015 Dun-Sol Go, Young-Eun Kim, Munkhzul Radnaabaatar, Yunsun Jung, Jaehun Jung, Seok-Jun Yoon Journal of Korean Medical Science.2019;[Epub] CrossRef
Morin enhances auranofin anticancer activity by up‐regulation of DR4 and DR5 and modulation of Bcl‐2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells Hyun Hwang‐Bo, Won Sup Lee, Arulkumar Nagappan, Hong Jae Kim, Radha Panchanathan, Cheol Park, Seong‐Hwan Chang, Nam Deuk Kim, Sun‐Hee Leem, Young‐Chae Chang, Taeg Kyu Kwon, Jae Hun Cheong, Gon Sup Kim, Jin‐Myung Jung, Sung Chul Shin, Soon Chan Hong, Yung Phytotherapy Research.2019; 33(5): 1384. CrossRef
The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha Cancer Research and Treatment.2019; 51(4): 1411. CrossRef
Cancer Incidence Trend in the Hebei Spirit Oil Spill Area, from 1999 to 2014: An Ecological Study Kyung-Hwa Choi, Myung-Sook Park, Mina Ha, Jong-Il Hur, Hae-Kwan Cheong International Journal of Environmental Research and Public Health.2018; 15(5): 1006. CrossRef
Gut Microbiota in Tibetan Herdsmen Reflects the Degree of Urbanization Huan Li, Tongtong Li, Xiangzhen Li, Guanhong Wang, Qiang Lin, Jiapeng Qu Frontiers in Microbiology.2018;[Epub] CrossRef
Regional Differences in Years of Life Lost in Korea from 1997 to 2015 Dun-Sol Go, Young-Eun Kim, Munkhzul Radnaabaatar, Yunsun Jung, Jaehun Jung, Seok-Jun Yoon Journal of Korean Medical Science.2018;[Epub] CrossRef
Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method Seesai Yeesoonsang, Surichai Bilheem, Edward McNeil, Sophon Iamsirithaworn, Chuleeporn Jiraphongsa, Hutcha Sriplung Cancer Research and Treatment.2017; 49(1): 54. CrossRef
Prognostic impact of Ki-67 in patients with gastric cancer—the importance of depth of invasion and histologic differentiation Gyung Hyuck Ko, Se-Il Go, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha Medicine.2017; 96(25): e7181. CrossRef
Recent urbanization in China is correlated with a Westernized microbiome encoding increased virulence and antibiotic resistance genes Kathryn Winglee, Annie Green Howard, Wei Sha, Raad Z. Gharaibeh, Jiawu Liu, Donghui Jin, Anthony A. Fodor, Penny Gordon-Larsen Microbiome.2017;[Epub] CrossRef
Purpose
The present study is to investigate the significance of CD44 variant 9 (CD44v9) expression as a biomarker in primary gastric cancer.
Materials and Methods
With various gastric tissues, we performed immunohistochemical staining for CD44v9.
Results
The positive expression rates for CD44v9 in tumor, including adenoma, early gastric cancer (EGC), and advanced gastric cancer (AGC), were higher than those in non-tumor tissues (p = 0.003). In addition, the higher expression for CD44v9 was observed as the tissue becomes malignant. In the analysis of 333 gastric cancer tissues, we found that positive expression rates for CD44v9 were higher in the intestinal type or well differentiated gastric cancer than in the diffuse type or poorly differentiated gastric cancer. Interestingly, the positive expression indicated poor prognosis in EGC (5-YSR in stage I, 81.7% vs 95.2%; p = 0.013), but not in AGC (5-YSR in stage II, 66.9% vs 62.2%; p = 0.821, 5-YSR in stage III, 34.5% vs 32.0%; p = 0.929). Moreover, strong positive expression (3+) showed a trend suggesting worse prognosis only in EGC, and it appeared to be associated with lymph node metastasis.
Conclusion
This study suggests that CD44v9 may be a good biomarker for prognosis prediction and for chemoprevention or biomarker-driven therapies only for EGC.
Can Nano Yield Big Insights? Oligonucleotide-Based Biosensors in Early Diagnosis of Gastric Cancer Alexandra E. Avanu, Alexandra M. Ciubotariu, Gianina Dodi Chemosensors.2024; 12(3): 44. CrossRef
Diagnostic and prognostic value of CD44v9 and TIM3 expression in CK‑ and CK+ regions in gastric cancer tissues Xiaofei Wang, Lin Lu, Ruidong Yang, Zhiwu Wang, Qingke Li, Jingwu Li, Yankun Liu Oncology Letters.2024;[Epub] CrossRef
Late recurrent gastric carcinoma 12 years after surgery with attenuation of CD44 variant 9 expression Hirokatsu Hayashi, Itaru Yasufuku, Toshiya Higashi, Wakana Chikaishi, Ryoma Yokoi, Masahiro Fukada, Yuta Sato, Ryuichi Asai, Jesse Yu Tajima, Chiemi Saigo, Akitaka Makiyama, Yoshihiro Tanaka, Naoki Okumura, Katsutoshi Murase, Takao Takahashi, Manabu Futam Surgical Case Reports.2023;[Epub] CrossRef
The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer Nicola Cirillo International Journal of Molecular Sciences.2023; 24(21): 15812. CrossRef
Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha Current Issues in Molecular Biology.2022; 44(3): 1395. CrossRef
Molecular pathogenesis and emerging targets of gastric adenocarcinoma Abby Ivey, Hillary Pratt, Brian A. Boone Journal of Surgical Oncology.2022; 125(7): 1079. CrossRef
Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis Mahdieh Razmi, Roya Ghods, Somayeh Vafaei, Maryam Sahlolbei, Leili Saeednejad Zanjani, Zahra Madjd Cancer Cell International.2021;[Epub] CrossRef
CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations Mohammad Mahmoudi Gomari, Marziye Farsimadan, Neda Rostami, Zahra mahmoudi, Mahmood Fadaie, Ibrahim Farhani, Parastoo Tarighi Mutation Research/Reviews in Mutation Research.2021; : 108374. CrossRef
Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation Tomoko Jogo, Eiji Oki, Ryota Nakanishi, Koji Ando, Yuichiro Nakashima, Yasue Kimura, Hiroshi Saeki, Yoshinao Oda, Yoshihiko Maehara, Masaki Mori Gastric Cancer.2021; 24(5): 1089. CrossRef
Current therapeutic options for gastric adenocarcinoma C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad Saudi Journal of Biological Sciences.2021; 28(9): 5371. CrossRef
Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer Luis Enrique Cortés-Hernández, Zahra Eslami-S, Catherine Alix-Panabières Molecular Aspects of Medicine.2020; 72: 100816. CrossRef
Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation Takahiro Shimizu, Yoojin Sohn, Eunyoung Choi, Christine P. Petersen, Nripesh Prasad, James R. Goldenring Cellular and Molecular Gastroenterology and Hepatology.2020; 9(1): 61. CrossRef
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer Jie Yang Medical Oncology.2020;[Epub] CrossRef
Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa Katherine M Riera, Bogun Jang, Jimin Min, Joseph T Roland, Qing Yang, William T Fesmire, Sophie Camilleri‐Broet, Lorenzo Ferri, Woo H Kim, Eunyoung Choi, James R Goldenring The Journal of Pathology.2020; 251(3): 336. CrossRef
Prognostic value of CD44v9 expression in human cancers: Retraction Li Zeng, Yitian Chen, Ligang Chen, Chengwei Tang Medicine.2020; 99(30): e20428. CrossRef
Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression Jinfen Wei, Meiling Hu, Kaitang Huang, Shudai Lin, Hongli Du International Journal of Molecular Sciences.2020; 21(17): 5983. CrossRef
The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation Takaki Akamine, Tetsuzo Tagawa, Kayo Ijichi, Gouji Toyokawa, Shinkichi Takamori, Fumihiko Hirai, Tatsuro Okamoto, Yoshinao Oda, Yoshihiko Maehara Annals of Surgical Oncology.2019; 26(5): 1544. CrossRef
Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori–Infected CAPZA1-Overexpressing Cells Hitoshi Tsugawa, Chihiro Kato, Hideki Mori, Juntaro Matsuzaki, Kaori Kameyama, Hideyuki Saya, Masanori Hatakeyama, Makoto Suematsu, Hidekazu Suzuki Cellular and Molecular Gastroenterology and Hepatology.2019; 8(3): 319. CrossRef
hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing Wei-zhao Peng, Ji-xi Liu, Chao-feng Li, Ren Ma, Jian-zheng Jie Cancer Cell International.2019;[Epub] CrossRef
The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha Cancer Research and Treatment.2019; 51(4): 1411. CrossRef
Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer Masayuki Hagiwara, Eiji Kikuchi, Nobuyuki Tanaka, Takeo Kosaka, Shuji Mikami, Hideyuki Saya, Mototsugu Oya BMC Cancer.2018;[Epub] CrossRef
Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma Noriko Hiyama, Takahiro Ando, Keita Maemura, Toshio Sakatani, Yosuke Amano, Kousuke Watanabe, Hidenori Kage, Yutaka Yatomi, Takahide Nagase, Jun Nakajima, Daiya Takai Japanese Journal of Clinical Oncology.2018; 48(4): 303. CrossRef
Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation Nattawan Suwannakul, Ning Ma, Raynoo Thanan, Somchai Pinlaor, Piti Ungarreevittaya, Kaoru Midorikawa, Yusuke Hiraku, Shinji Oikawa, Shosuke Kawanishi, Mariko Murata Mediators of Inflammation.2018; 2018: 1. CrossRef
Expression of CD44, CD44v9, ABCG2, CD24, Bmi‑1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors Tetsuya Tamatani, Natsumi Takamaru, Go Ohe, Kazuya Akita, Takayuki Nakagawa, Youji Miyamoto Oncology Letters.2018;[Epub] CrossRef
Hyaluronic acid in digestive cancers Ruo-Lin Wu, Lei Huang, Hong-Chuan Zhao, Xiao-Ping Geng Journal of Cancer Research and Clinical Oncology.2017; 143(1): 1. CrossRef
Prognostic impact of Ki-67 in patients with gastric cancer—the importance of depth of invasion and histologic differentiation Gyung Hyuck Ko, Se-Il Go, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha Medicine.2017; 96(25): e7181. CrossRef
Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205) Kohei Shitara, Toshihiko Doi, Osamu Nagano, Chiyo K. Imamura, Takeshi Ozeki, Yuya Ishii, Kenji Tsuchihashi, Shunji Takahashi, Takako E. Nakajima, Shuichi Hironaka, Miki Fukutani, Hiromi Hasegawa, Shogo Nomura, Akihiro Sato, Yasuaki Einaga, Takeshi Kuwata, Gastric Cancer.2017; 20(2): 341. CrossRef
CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues Yushi YAMAKAWA, Masatoshi KUSUHARA, Masanori TERASHIMA, Yusuke KINUGASA, Takashi SUGINO, Masato ABE, Toru MOCHIZUKI, Keiichi HATAKEYAMA, Kenjiro KAMI, Ken YAMAGUCHI Biomedical Research.2017; 38(1): 41. CrossRef
Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells Yana Zavros Cellular and Molecular Gastroenterology and Hepatology.2017; 4(1): 55. CrossRef
Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407) Kohei Shitara, Toshihiko Doi, Osamu Nagano, Miki Fukutani, Hiromi Hasegawa, Shogo Nomura, Akihiro Sato, Takeshi Kuwata, Kai Asai, Yasuaki Einaga, Kenji Tsuchihashi, Kentaro Suina, Yusuke Maeda, Hideyuki Saya, Atsushi Ohtsu Gastric Cancer.2017; 20(6): 1004. CrossRef
Hypoxia regulates CD44 expression via hypoxia-inducible factor-1α in human gastric cancer cells Gai Liang, Shuang Li, Wei Du, Qinghua Ke, Jun Cai, Jiyuan Yang Oncology Letters.2017; 13(2): 967. CrossRef
Variant isoforms of CD44 expression in upper tract urothelial cancer as a predictive marker for recurrence and mortality Masayuki Hagiwara, Eiji Kikuchi, Takeo Kosaka, Shuji Mikami, Hideyuki Saya, Mototsugu Oya Urologic Oncology: Seminars and Original Investigations.2016; 34(8): 337.e19. CrossRef
Cancer stem cells in human digestive tract malignancies Fatemeh B. Rassouli, Maryam M. Matin, Morvarid Saeinasab Tumor Biology.2016; 37(1): 7. CrossRef
Subcutaneous panniculitis-like T cell lymphoma (SPTL) is a distinctive cutaneous
lymphoma characterized by an infiltration of subcutaneous tissue by neoplastic T cells, similar to panniculitis. It is well-established that patients who are diagnosed with SPTL usually respond poorly to chemotherapy, showing fatal outcome. As a first line treatment for SPTL, anthracycline-based chemotherapy was most frequently used. For the treatment of SPTL, the efficacy of cyclosporine A has been recently reported in relapsed SPTL after anthracycline-based chemotherapy. However, it is still not clear whether cyclosporine A can be used as a first-line treatment against SPTL. Here, we report a case of SPTL, which achieved complete remission for nine years after first-line cyclosporine A therapy. This study suggests that cyclosporine A can induce a complete long-term remission as a first-line treatment.
Citations
Citations to this article as recorded by
The pathophysiology and current treatments for the subcutaneous panniculitis‐like T cell lymphoma: An updated review En‐Cheng Lin, Jia‐Bin Liao, Yu‐Han Fang, Chien‐Hui Hong Asia-Pacific Journal of Clinical Oncology.2023; 19(1): 27. CrossRef
A retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy? Yanlong Duan, Huixia Gao, Chunju Zhou, Ling Jin, Jing Yang, Shuang Huang, Meng Zhang, Yonghong Zhang, Tianyou Wang Orphanet Journal of Rare Diseases.2022;[Epub] CrossRef
Case Report—Indurated Plaques and Recurrent Fevers in a 37-Year-Old Man: Answer Elizabeth Dao, Alexandra Bourgeois, Pamela Martin The American Journal of Dermatopathology.2021; 43(10): 754. CrossRef
Hemophagocytic Lymphohistiocytosis as the Initial Presentation of Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Rare Case Responding to Cyclosporine A and Steroids Caitlin Sullivan, Arya Loghmani, Katharine Thomas, Rachna Jetly-Shridhar, Rajasree Pia Chowdry Journal of Investigative Medicine High Impact Case Reports.2020;[Epub] CrossRef
Rare Cutaneous T-Cell Lymphomas Fabiana Damasco, Oleg E. Akilov Hematology/Oncology Clinics of North America.2019; 33(1): 135. CrossRef
Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian population Ting-An Lin, Ching-Fen Yang, Yao-Chung Liu, Jin-Hwang Liu, Tzeon-jye Chiou, Liang-Tsai Hsiao, Hsiu-Ju Yen, Chia-Jen Liu, Hao-Yuan Wang, Po-Shen Ko, Sheng-Hsuan Chien, Jyh-Pyng Gau International Journal of Hematology.2019; 109(2): 187. CrossRef
Successful treatment of a rare subcutaneous panniculitis‐like T‐cell lymphoma: An unusual case report and literature review Liye Xu, Yuxuan Che, Xiaolei Ding, Jincheng Song, Xian Zhang, Xiuhua Sun Dermatologic Therapy.2019;[Epub] CrossRef
British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018 J. Berth‐Jones, L.S. Exton, E. Ladoyanni, M.F. Mohd Mustapa, V.M. Tebbs, P.D. Yesudian, N.J. Levell, P.M. McHenry, T.A. Leslie, S. Wakelin, R.Y.P. Hunasehally, M. Cork, G.A. Johnston, N. Chiang, F.S. Worsnop, A. Salim, D. Buckley, G. Petrof, N. Callachand British Journal of Dermatology.2019; 180(6): 1312. CrossRef
A Systematic Approach to the Cutaneous Lymphoid Infiltrates: A Clinical, Morphologic, and Immunophenotypic Evaluation Alejandro A. Gru, Chauncey McHargue, Andrea L. Salavaggione Archives of Pathology & Laboratory Medicine.2019; 143(8): 958. CrossRef
Hemophagocytic lymphohistiocytosis: A rare, potentially fatal complication in subcutaneous panniculitis like T cell lymphoma ChandraSekhar Sirka, Swetalina Pradhan, Susama Patra, Somanath Padhi, SarojKumar DasMajumdar, Debjani Panda Indian Journal of Dermatology, Venereology and Leprology.2019; 85(5): 481. CrossRef
Subcutaneous panniculitis-like T-Cell lymphoma: A mixed diagnostic approach to diagnosing a vague clinical picture Callie Roberts Hill, Apphia Wang, Boni E. Elewski, Peter G Pavlidakey SKIN The Journal of Cutaneous Medicine.2019; 3(2): 90. CrossRef
Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas Pilvi Maliniemi, Kirsi Laukkanen, Liisa Väkevä, Katja Dettmer, Tuomas Lipsanen, Leila Jeskanen, Alban Bessede, Peter J. Oefner, Marshall E. Kadin, Annamari Ranki OncoImmunology.2017; 6(3): e1273310. CrossRef
Uncommon Variants of T-Cell Lymphomas Neha Mehta-Shah, Steven Horwitz Hematology/Oncology Clinics of North America.2017; 31(2): 285. CrossRef
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review Chi-Ching Chen, Chieh-Lin Teng, Su-Peng Yeh Annals of Hematology.2016; 95(5): 837. CrossRef
Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides Meenal Kheterpal, Neha Mehta-Shah, Pooja Virmani, Patricia L. Myskowski, Alison Moskowitz, Steven M. Horwitz Current Hematologic Malignancy Reports.2016; 11(3): 224. CrossRef
Zebras and hen's teeth: recognition and management of rare T and NK lymphomas Neha Mehta–Shah, Steven Horwitz Hematology.2015; 2015(1): 545. CrossRef